These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2466127)

  • 21. In vitro and in vivo regulation of tumor antigen expression by human recombinant interferons.
    Guadagni F; Schlom J; Greiner JW
    Int J Rad Appl Instrum B; 1991; 18(4):409-12. PubMed ID: 1907601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells.
    Greiner JW; Guadagni F; Goldstein D; Smalley RV; Borden EC; Simpson JF; Molinolo A; Schlom J
    J Clin Oncol; 1992 May; 10(5):735-46. PubMed ID: 1569446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons.
    Tran R; Hand PH; Greiner JW; Pestka S; Schlom J
    J Interferon Res; 1988 Feb; 8(1):75-88. PubMed ID: 3130426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen.
    Roselli M; Guadagni F; Buonomo O; Belardi A; Vittorini V; Mariani-Costantini R; Greiner JW; Casciani CU; Schlom J
    J Clin Oncol; 1996 Jul; 14(7):2031-42. PubMed ID: 8683233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential responsiveness of cloned mammary carcinoma cell populations to the human recombinant leukocyte interferon enhancement of tumor antigen expression.
    Greiner JW; Tobi M; Fisher PB; Langer JA; Pestka S
    Int J Cancer; 1985 Aug; 36(2):159-66. PubMed ID: 3160671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells.
    Guadagni F; Schlom J; Johnston WW; Szpak CA; Goldstein D; Smalley R; Simpson JF; Borden EC; Pestka S; Greiner JW
    J Natl Cancer Inst; 1989 Apr; 81(7):502-12. PubMed ID: 2466127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of tumor antigen expression by recombinant human interferons: enhanced targeting of monoclonal antibodies to carcinomas.
    Greiner JW; Guadagni F; Hand PH; Pestka S; Noguchi P; Fisher PB; Schlom J
    Cancer Treat Res; 1990; 51():413-32. PubMed ID: 1977458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo regulation of human tumor antigen expression by human recombinant interferons: a review.
    Guadagni F; Roselli M; Schlom J; Greiner JW
    Int J Biol Markers; 1994; 9(1):53-60. PubMed ID: 7519653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel clinical approaches in monoclonal antibody-based management in colorectal cancer patients: radioimmunoguided surgery and antigen augmentation.
    Roselli M; Buonomo O; Piazza A; Guadagni F; Vecchione A; Brunetti E; Cipriani C; Amadei G; Nieroda C; Greiner JW; Casciani CU
    Semin Surg Oncol; 1998 Dec; 15(4):254-62. PubMed ID: 9829383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of human tumor antigen expression.
    Greiner JW; Hand PH; Colcher D; Weeks M; Thor A; Noguchi P; Pestka S; Schlom J
    J Lab Clin Med; 1987 Mar; 109(3):244-61. PubMed ID: 2434589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological response modifiers as adjuvants in monoclonal antibody-based treatment (review).
    Guadagni F; Roselli M; Nieroda C; Dansky-Ullmann G; Schlom J; Greiner JW
    In Vivo; 1993; 7(6B):591-9. PubMed ID: 8193280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the type I interferons in allograft rejection.
    Tovey MG; Benizri E; Gugenheim J; Bernard G; Eid P; Blanchard B; Hofman P
    J Leukoc Biol; 1996 Apr; 59(4):512-7. PubMed ID: 8613698
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.